PUNE, India, September 28, 2017 /PRNewswire/ --
"Global Antibody Drug Conjugates (ADC) Market Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analyzed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. Antibody Drug Conjugates Market (ADC) is projected to display a robust growth represented by a CAGR of 21.82% during 2017 - 2022, driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates according to ReportsnReports.com.
Browse 97 Tables and Figures, 10 Companies Profiles spread across 154 pages at http://www.reportsnreports.com/reports/927058-global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022-by-region-n-america-europe-apac-row-by-country-u-th-africa.html.
(This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / [email protected] )
Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs. Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years.
The Antibody Drug Conjugates (ADC) Market report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market.
Order a copy of report at http://www.reportsnreports.com/purchase.aspx?name=927058.
(This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / [email protected] )
Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status and ADC Pipeline - By Cytotoxic Payload, Linker and Target
Regional Markets - N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status and ADC Pipeline - By Cytotoxic Payload, Linker and Target
Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market
Other Report Highlights: Market Dynamics - Trends, Drivers, Challenges, Porter's Five Forces Analysis, SWOT Analysis and Policy and Regulation
Other related report "Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022)" global market is projected to display a robust growth represented by a CAGR of 9.15% during 2017 - 2022, chiefly driven by aging population and rising incidences of orthopaedic disorders. Over the recent years, the global Collagen Biomaterial industry has been growing rapidly owing to aging population, rising number of people with orthopedic disorders and high demand in bone graft substitute and wound healing market. Globally, the growth in Collagen Biomaterial market is driven by increased investment in research & development.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.
Contact: Hrishikesh Patwardhan 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India. +1-888-391-5441 [email protected]
Connect With Us On: http://www.reportsnreports.com/feed/p-210-azoth-analytics.xml
LinkedIn: http://www.linkedin.com/company/reportsnreports
SOURCE ReportsnReports
Advertisement
"Global Antibody Drug Conjugates (ADC) Market Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analyzed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. Antibody Drug Conjugates Market (ADC) is projected to display a robust growth represented by a CAGR of 21.82% during 2017 - 2022, driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates according to ReportsnReports.com.
Advertisement
Browse 97 Tables and Figures, 10 Companies Profiles spread across 154 pages at http://www.reportsnreports.com/reports/927058-global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022-by-region-n-america-europe-apac-row-by-country-u-th-africa.html.
(This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / [email protected] )
Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs. Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years.
The Antibody Drug Conjugates (ADC) Market report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market.
Order a copy of report at http://www.reportsnreports.com/purchase.aspx?name=927058.
(This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / [email protected] )
Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status and ADC Pipeline - By Cytotoxic Payload, Linker and Target
Regional Markets - N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status and ADC Pipeline - By Cytotoxic Payload, Linker and Target
Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market
Other Report Highlights: Market Dynamics - Trends, Drivers, Challenges, Porter's Five Forces Analysis, SWOT Analysis and Policy and Regulation
Other related report "Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022)" global market is projected to display a robust growth represented by a CAGR of 9.15% during 2017 - 2022, chiefly driven by aging population and rising incidences of orthopaedic disorders. Over the recent years, the global Collagen Biomaterial industry has been growing rapidly owing to aging population, rising number of people with orthopedic disorders and high demand in bone graft substitute and wound healing market. Globally, the growth in Collagen Biomaterial market is driven by increased investment in research & development.
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.
Contact: Hrishikesh Patwardhan 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India. +1-888-391-5441 [email protected]
Connect With Us On: http://www.reportsnreports.com/feed/p-210-azoth-analytics.xml
LinkedIn: http://www.linkedin.com/company/reportsnreports
SOURCE ReportsnReports
